These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23883545)

  • 41. [Comprehensive risk management chart for the prevention of cerebro- and cardiovascular diseases].
    Joint Committee for Comprehensive Risk Management Chart for the Prevention of Cerebro- and Cardiovascular Diseases
    Nihon Naika Gakkai Zasshi; 2015 Apr; 104(4):824-59. PubMed ID: 26536749
    [No Abstract]   [Full Text] [Related]  

  • 42. Chronic kidney disease.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2014; 21(3):173-4. PubMed ID: 24335041
    [No Abstract]   [Full Text] [Related]  

  • 43. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
    ; Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Perrone Filardi P; Riccardi G; Storey RF; Wood D;
    Atherosclerosis; 2011 Jul; 217 Suppl 1():S1-44. PubMed ID: 21723445
    [No Abstract]   [Full Text] [Related]  

  • 44. [Atherosclerosis: progress in diagnosis and treatments. Editorial: prevention of atherosclerotic diseases through diagnosis and management of the risk factors].
    Teramoto T
    Nihon Naika Gakkai Zasshi; 2013 Feb; 102(2):271-3. PubMed ID: 23767305
    [No Abstract]   [Full Text] [Related]  

  • 45. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update.
    Genest J; Frohlich J; Fodor G; McPherson R;
    CMAJ; 2003 Oct; 169(9):921-4. PubMed ID: 14581310
    [No Abstract]   [Full Text] [Related]  

  • 46. Status of lipid management using lifestyle modification in Japanese adults: an analysis of the 2009 Japan Society of Ningen Dock database.
    Takahashi E; Moriyama K; Yamakado M
    Intern Med; 2013; 52(15):1681-6. PubMed ID: 23903499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time for results: a better way to reduce cardiovascular risk.
    Mola A; Lloyd M
    Adv Nurse Pract; 2002 Apr; 10(4):34-41; quiz 42-3. PubMed ID: 12418348
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical practice guidelines for the management of dyslipidemia.
    Nichols N
    Can J Cardiovasc Nurs; 2004; 14(2):7-10. PubMed ID: 15230023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular disease risk assessment and prevention: current guidelines and limitations.
    Alagona P; Ahmad TA
    Med Clin North Am; 2015 Jul; 99(4):711-31. PubMed ID: 26042878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathways Forward in Cardiovascular Disease Prevention One and a Half Years After Publication of the 2013 ACC/AHA Cardiovascular Disease Prevention Guidelines.
    Cainzos-Achirica M; Desai CS; Wang L; Blaha MJ; Lopez-Jimenez F; Kopecky SL; Blumenthal RS; Martin SS
    Mayo Clin Proc; 2015 Sep; 90(9):1262-71. PubMed ID: 26269108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comments for 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults].
    Zhang X; Hu D
    Zhonghua Nei Ke Za Zhi; 2015 Jan; 54(1):9-12. PubMed ID: 25877138
    [No Abstract]   [Full Text] [Related]  

  • 52. 2013 American Heart Association/American College of Cardiology Guideline on Lifestyle Management to Reduce Cardiovascular Risk: practice opportunities for registered dietitian nutritionists.
    Millen BE; Wolongevicz DM; de Jesus JM; Nonas CA; Lichtenstein AH
    J Acad Nutr Diet; 2014 Nov; 114(11):1723-9. PubMed ID: 25439080
    [No Abstract]   [Full Text] [Related]  

  • 53. [Consensus standpoints from expert panel of Chinese Society of Cardiology on AHA/ACC 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults].
    Yan X; Chen H; Gao W; Li J; Yang X; Ye P; Zhang S; Zhao D; Zhu J; Huo Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):275-6. PubMed ID: 24924450
    [No Abstract]   [Full Text] [Related]  

  • 54. [The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)].
    Saruta T
    Nihon Rinsho; 2005 Jun; 63(6):952-8. PubMed ID: 15948375
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary.
    Bell AD; Roussin A; Cartier R; Chan WS; Douketis JD; Gupta A; Kraw ME; Lindsay TF; Love MP; Pannu N; Rabasa-Lhoret R; Shuaib A; Teal P; Théroux P; Turpie AG; Welsh RC; Tanguay JF
    Can J Cardiol; 2011; 27(2):208-21. PubMed ID: 21459270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.
    ; ; ; ; ;
    Heart; 2005 Dec; 91 Suppl 5(Suppl 5):v1-52. PubMed ID: 16365341
    [No Abstract]   [Full Text] [Related]  

  • 57. Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance.
    Rabar S; Harker M; O'Flynn N; Wierzbicki AS;
    BMJ; 2014 Jul; 349():g4356. PubMed ID: 25035388
    [No Abstract]   [Full Text] [Related]  

  • 58. [Controversies and advances in the treatment of hyperlipidemias].
    Reza-Albarrán A; Aguilar-Salinas CA
    Gac Med Mex; 1998; 134(2):253-6. PubMed ID: 9619005
    [No Abstract]   [Full Text] [Related]  

  • 59. Cardiovascular disease and hormone replacement therapy in post-menopausal women.
    Rapeport N
    Cardiovasc J S Afr; 2005; 16(2):76-80. PubMed ID: 15915271
    [No Abstract]   [Full Text] [Related]  

  • 60. [Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice].
    Royo-Bordonada MÁ; Armario P; Lobos Bejarano JM; Pedro-Botet J; Villar Álvarez F; Elosua R; Brotons Cuixart C; Cortés O; Serrano B; Camafort Babkowski M; Gil Núñez A; Pérez A; Maiques A; de Santiago Nocito A; de Castro A; Alegría E; Baeza C; Herranz M; Sans S; Campos P;
    Gac Sanit; 2017; 31(3):255-268. PubMed ID: 28292529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.